Clinical Trial Update: Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B [Phase 3]

View source ↗

Summary

Phase 3 trial comparing telbivudine to lamivudine in Chinese adults with compensated chronic hepatitis B; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)
• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED